Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 13, 2020
Total Value: $1.349B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| NTRA | Natera | 3,100,560 | $224M | 16.6% | $72.24 * | $9.81 | +479.6% | COMM | 632307104 |
| ASND | Ascendis Pharma A/S | 1,109,874 | $171M | 12.7% | $154.32 | $69.98 | — | ADR | 04351P101 |
| — | Karuna Therapeutics, Inc. | 1,952,441 | $151M | 11.2% | $77.32 | $26.41 | — | COMM | 48576A100 |
| — | Y-mAbs Therapeutics, Inc | 2,194,278 | $84.24M | 6.2% | $38.39 | $26.75 | — | COMM | 984241109 |
| — | Inozyme Pharma, Inc. | 2,028,308 | $53.32M | 4.0% | $26.29 | $26.29 | — | COMM | 45790W108 |
| — | Checkmate Pharmaceuticals Inc | 3,606,707 | $41.51M | 3.1% | $11.51 | $11.51 | — | COMM | 162818108 |
| — | Amgen Inc | 59,500 | $41.25M | 3.1% | $693.24 | — | — | Call | 031162900 |
| — | Akouos, Inc | 1,515,073 | $34.65M | 2.6% | $22.87 | $22.50 | — | ADR | 00973J101 |
| UTHR | United Therapeutics Corp | 320,959 | $32.42M | 2.4% | $101.00 * | $91.13 | +20.4% | COMM | 91307C102 |
| ABBV | Abbvie Inc | 341,340 | $29.9M | 2.2% | $87.59 * | $71.54 | +6.7% | COMM | 00287Y109 |
| — | Nucana Biomed Ltd | 5,599,999 | $28.95M | 2.1% | $5.17 | $9.47 | — | ADR | 67022C106 |
| AMGN | Amgen Inc | 111,619 | $28.37M | 2.1% | $254.16 * | $209.54 | 0.0% | COMM | 031162100 |
| GRTX | Galera Therapeutics, Inc | 3,083,712 | $27.88M | 2.1% | $9.04 * | $12.19 | -35.0% | COMM | 36338D108 |
| — | Nextcure, Inc | 2,671,856 | $23.51M | 1.7% | $8.80 | $17.30 | — | COMM | 65343E108 |
| LLY | Lilly Eli & Co | 142,432 | $21.08M | 1.6% | $148.02 | $143.90 | +1.3% | COMM | 532457108 |
| INSM | Insmed Inc | 615,143 | $19.77M | 1.5% | $32.14 * | $24.78 | +16.0% | COMM | 457669307 |
| BMRN | Biomarin Pharmaceutical Inc | 258,653 | $19.68M | 1.5% | $76.08 * | $95.51 | +5.9% | COMM | 09061G101 |
| PTCT | PTC Therapeutics Inc | 405,152 | $18.94M | 1.4% | $46.75 * | $43.59 | +12.9% | COMM | 69366J200 |
| JAZZ | Jazz Pharmaceuticals PLC | 130,268 | $18.57M | 1.4% | $142.59 * | $110.58 | +12.1% | COMM | G50871105 |
| MRK | Merck & Co Inc | 190,559 | $15.81M | 1.2% | $82.95 * | $66.37 | -0.7% | COMM | 58933Y105 |
| — | Merus N.V. | 1,311,039 | $15.73M | 1.2% | $12.00 | $18.53 | — | COMM | N5749R100 |
| — | Intra-Cellular Therapies Inc | 503,555 | $12.92M | 1.0% | $25.66 | $24.60 | — | COMM | 46116X101 |
| — | Nucana Biomed Ltd | 2,400,000 | $12.41M | 0.9% | $5.17 | $5.41 | — | Ordinary Shares | GBOOBYWYV |
| — | ObsEva SA | 4,749,623 | $11.78M | 0.9% | $2.48 | $13.49 | — | COMM | H5861P103 |
| — | Athira Pharma, Inc. | 509,168 | $9.399M | 0.7% | $18.46 | $18.46 | — | COMM | 04746L104 |
| — | Marinus Pharmaceuticals Inc | 175,000 | $8.995M | 0.7% | $51.40 | — | — | Call | 56854Q900 |
| — | Otonomy Inc | 2,111,596 | $8.551M | 0.6% | $4.05 | $3.16 | — | COMM | 68906L105 |
| — | GW Pharmaceuticals PLC | 82,944 | $8.075M | 0.6% | $97.35 | $97.35 | — | ADR | 36197T103 |
| CHRS | Coherus BioSciences | 434,555 | $7.97M | 0.6% | $18.34 | $10.94 | +70.0% | COMM | 19249H103 |
| CYTK | Cytokinetics Inc | 349,296 | $7.562M | 0.6% | $21.65 * | $21.26 | +10.0% | COMM | 23282W605 |
| — | Zymeworks Inc | 151,902 | $7.075M | 0.5% | $46.58 | $33.72 | — | COMM | 98985W102 |
| — | Cytokinetics Inc | 325,000 | $7.036M | 0.5% | $21.65 | — | — | Put | 23282W955 |
| PTGX | Protagonist Therapeutics Inc | 357,769 | $6.994M | 0.5% | $19.55 * | $13.10 | +43.3% | COMM | 74366E102 |
| KURA | Kura Oncology Inc | 225,259 | $6.902M | 0.5% | $30.64 * | $14.42 | +53.1% | COMM | 50127T109 |
| SUPN | Supernus Pharmaceuticals Inc | 330,295 | $6.883M | 0.5% | $20.84 * | $22.09 | +2.7% | COMM | 868459108 |
| TGTX | TG Therapeutics Inc | 250,401 | $6.7M | 0.5% | $26.76 * | $12.49 | +84.2% | COMM | 88322Q108 |
| — | Acceleron Pharma Inc | 59,546 | $6.7M | 0.5% | $112.52 | $57.73 | — | COMM | 00434H108 |
| — | Reata Pharmaceuticals Inc | 68,615 | $6.685M | 0.5% | $97.43 | $108.56 | — | COMM | 75615P103 |
| — | MyoKardia Inc | 48,998 | $6.68M | 0.5% | $136.33 | $60.83 | — | COMM | 62857M105 |
| — | Arena Pharmaceuticals Inc | 88,150 | $6.592M | 0.5% | $74.78 | $72.91 | — | COMM | 040047607 |
| OVID | Ovid Therapeutics Inc | 1,097,621 | $6.3M | 0.5% | $5.74 * | $6.69 | 0.0% | COMM | 690469101 |
| MIRM | Mirum Pharmaceuticals Inc | 321,252 | $6.191M | 0.5% | $19.27 * | $16.48 | +30.2% | COMM | 604749101 |
| — | Reata Pharmaceuticals Inc | 60,000 | $5.845M | 0.4% | $97.42 | — | — | Put | 75615P953 |
| — | Novocure Ltd | 50,000 | $5.566M | 0.4% | $111.32 | — | — | Call | G6674U908 |
| — | Amarin Corp | 1,170,584 | $4.928M | 0.4% | $4.21 | $7.81 | — | ADR | 023111206 |
| ACRS | Aclaris Therapeutics | 1,911,573 | $4.913M | 0.4% | $2.57 * | $19.07 | -88.3% | COMM | 00461U105 |
| PBYI | Puma Biotechnology Inc | 475,982 | $4.803M | 0.4% | $10.09 | $10.01 | +1.7% | COMM | 74587V107 |
| — | Chiasma | 1,047,354 | $4.504M | 0.3% | $4.30 | $1.49 | — | COMM | 16706W102 |
| — | ChemoCentryx Inc | 81,235 | $4.451M | 0.3% | $54.79 | $45.16 | — | COMM | 16383L106 |
| — | Kiniksa Pharmaceuticals, Ltd | 276,628 | $4.238M | 0.3% | $15.32 | $17.35 | — | COMM CL A | G5269C101 |
| — | Applied Genetic Technologies Corp | 825,071 | $4.01M | 0.3% | $4.86 | $3.44 | — | COMM | 03820J100 |
| — | Moderna Inc | 50,000 | $3.537M | 0.3% | $70.74 | — | — | Call | 60770K907 |
| — | TCR2 Therapeutics Inc | 173,028 | $3.516M | 0.3% | $20.32 | $20.32 | — | COMM | 87808K106 |
| IMTX | Immatics NV | 325,527 | $3.453M | 0.3% | $10.61 | $10.53 | 0.0% | COMM | N44445109 |
| LQDA | Liquidia Technologies Inc | 679,400 | $3.342M | 0.2% | $4.92 * | $7.59 | -23.8% | COMM | 53635D202 |
| BCRX | BioCryst Pharmaceuticals Inc | 793,054 | $2.725M | 0.2% | $3.44 * | $3.54 | +21.1% | COMM | 09058V103 |
| — | Homology Medicines Inc | 238,015 | $2.547M | 0.2% | $10.70 | $15.90 | — | COMM | 438083107 |
| — | Kadmon Holdings Inc | 629,923 | $2.468M | 0.2% | $3.92 | $2.74 | — | COMM | 48283N106 |
| CGEN | Compugen Ltd | 146,592 | $2.383M | 0.2% | $16.26 | $10.36 | +58.2% | COMM | M25722105 |
| — | Entasis Therapeutics Holdings Inc. | 1,012,408 | $2.065M | 0.2% | $2.04 | $10.88 | — | COMM | 293614103 |
| ACAD | ACADIA Pharmaceuticals Inc | 48,996 | $2.022M | 0.1% | $41.27 * | $43.18 | 0.0% | COMM | 004225108 |
| — | Calithera Biosciences Inc | 493,297 | $1.701M | 0.1% | $3.45 | $4.49 | — | COMM | 13089P101 |
| FATE | Fate Therapeutics Inc | 41,400 | $1.654M | 0.1% | $39.95 * | $34.92 | 0.0% | COMM | 31189P102 |
| RGNX | Regenxbio Inc | 59,507 | $1.638M | 0.1% | $27.53 * | $32.60 | 0.0% | COMM | 75901B107 |
| — | Synlogic Inc. | 574,972 | $1.161M | 0.1% | $2.02 | $9.38 | — | COMM | 87166L100 |
| SVRA | Savara Inc | 375,591 | $409K | 0.0% | $1.09 * | $1.71 | 0.0% | COMM | 805111101 |
| PDSB | PDS Biotechnology Corporation | 142,635 | $332K | 0.0% | $2.33 * | $8.36 | -66.5% | COMM | 70465T107 |
| — | Kadmon Holdings Inc | 240,091 | $137K | 0.0% | $0.57 | $0.57 | — | Warrant | 48283N114 |